Commerce.com, Inc. (CMRC)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	363	480	740	644	2,533	4,436
Market Cap Growth	-35.70%	-35.21%	14.93%	-74.57%	-42.90%	-
Enterprise Value	394	533	825	688	2,474	4,296
Last Close Price	4.49	6.12	9.73	8.74	35.37	64.15
Forward PE	18.50	24.31	46.09	-	-	-
PS Ratio	1.05	1.44	2.39	2.31	11.52	29.11
PB Ratio	9.31	14.38	29.00	14.10	18.32	20.47
P/TBV Ratio	-	-	-	-	41.65	20.47
P/FCF Ratio	13.15	21.29	-	-	-	-
P/OCF Ratio	11.37	18.27	-	-	-	-
EV/Sales Ratio	1.17	1.60	2.67	2.46	11.25	28.19
EV/FCF Ratio	14.30	23.67	-	-	-	-
Debt / Equity Ratio	4.28	6.61	13.70	7.67	2.52	0.07
Debt / FCF Ratio	6.02	9.79	-	-	-	-
Asset Turnover	0.89	0.85	0.67	0.54	0.53	0.92
Quick Ratio	1.90	2.57	4.35	4.30	7.00	5.28
Current Ratio	2.13	2.86	4.83	4.75	7.24	5.54
Return on Equity (ROE)	-55.85%	-91.78%	-181.65%	-152.12%	-43.19%	-41.00%
Return on Assets (ROA)	-2.22%	-4.25%	-7.59%	-11.90%	-7.91%	-14.54%
Return on Capital (ROIC)	-2.89%	-5.30%	-9.04%	-13.88%	-9.15%	-18.72%
Earnings Yield	-5.00%	-5.63%	-8.73%	-21.72%	-3.03%	-0.85%
FCF Yield	7.60%	4.70%	-3.84%	-14.68%	-1.72%	-0.64%
Buyback Yield / Dilution	-3.13%	-3.27%	-2.62%	-3.23%	-81.45%	-119.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.